Moberg Pharma — Major Shareholding Notification 2015

Aug 13, 2015

Issuer Moberg Pharma AB (publ)

Holder

Kingdon Capital Management, L.L.C.

Instrument

Instrument	Ordinary shares SE0003613090
Before the transaction
Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification Buy
Date	11/08/2015
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	706,000
Directly held voting rights	0
Indirectly held voting rights	706,000
Percentage
Directly held shares	5.04 %
Directly held voting rights	0 %
Indirectly held voting rights	5.04 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares

Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3

• Physically settled
• Cash settled

Total

Chain of controlling companies

Voting rights % Voting rights Company

255,610 1.83 Kingdon Associates

• 393,944 2.81 M. Kingdon Offshore Master Fund L.P.
• 56,446 0.4 Kingdon Family Partners, L.P.

Group total holdings

Voting rights 706,000 Percentage of voting rights 5.04

Published

13/08/2015 15:09 Contact Name Dennis Bertron Phone +1 (212) 333-0100 Email legal@kingdon.com

*Source of information has chosen not to submit the data

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25